---
title: "Elite Health 2025 10-K: $1.024M Revenue, $(0.35) EPS"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282858697.md"
description: "Elite Health reported $1.024 million in revenue for 2025, primarily from PSS employee-leasing services after a November acquisition, with a net loss of $(7.804) million and a loss per share of $(0.35). The company is pivoting to Medicare Advantage operations, focusing on California, and has made operational investments to support this shift. The financial results reflect early contributions from the acquisition and ongoing investments. Elite Health raised funds through private placements to support operations into 2026."
datetime: "2026-04-15T13:55:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282858697.md)
  - [en](https://longbridge.com/en/news/282858697.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282858697.md)
generator: "portal-rs"
---

# Elite Health 2025 10-K: $1.024M Revenue, $(0.35) EPS

Elite Health reported $1.024 million in revenue for the year ended December 31, 2025, primarily from PSS employee-leasing services following a November 2025 acquisition, and recorded a loss per share of $(0.35) as net loss widened. The company posted an operating loss and a net loss for the year as it invested in launching Medicare Advantage operations and absorbed acquisition-related items. These results reflect the early contribution of the acquired business and investments to support the company's strategic pivot.

**Financial Highlights**

-   **Revenue**: $1.024 million, recorded from PSS employee-leasing revenue for two months after the November 2025 acquisition.
-   **Gross Profit**: $0.118 million, reported as Revenue less Cost of revenue.
-   **Operating Income**: $(3.839) million, reported as operating loss (selling, general and administrative expense of $3.957 million).
-   **Net Income**: $(7.804) million, reported as net loss for the year ended December 31, 2025.
-   **Net Income Per Share**: $(0.35), basic and diluted net loss per share attributable to Elite Health.

**Business Highlights**

-   **Acquisition and Immediate Contribution**: Acquired PSS in November 2025, which added goodwill and accounts receivable and generated immediate service revenue from employee-leasing operations.
-   **Strategic Pivot**: Executing a shift to build and operate Medicare Advantage plans, with initial focus on California.
-   **Operational Investments**: Capitalized expenditures on software and website development to support the launch of Medicare Advantage operations.
-   **Going Concern and Funding**: Raised private placement proceeds in 2025 to fund the Medicare Advantage launch and support operations into 2026.

Original SEC Filing: Elite Health Systems Inc. \[ EHSI \] - 10-K - Apr. 15, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [EHTH.US](https://longbridge.com/en/quote/EHTH.US.md)
- [CYH.US](https://longbridge.com/en/quote/CYH.US.md)
- [SSY.US](https://longbridge.com/en/quote/SSY.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XHS.US](https://longbridge.com/en/quote/XHS.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)

## Related News & Research

- [Vishnusurya Projects and Infra's (NSE:VISHNUINFR) Weak Earnings May Only Reveal A Part Of The Whole Picture](https://longbridge.com/en/news/305559929.md)
- [Pondy Oxides And Chemicals Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected](https://longbridge.com/en/news/305560101.md)
- [Alkem Laboratories Limited (NSE:ALKEM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates](https://longbridge.com/en/news/305559747.md)
- [RioCan Real Estate Investment Trust (TSX:REI.UN) Expands Its Buyback Program, Is It Still Undervalued?](https://longbridge.com/en/news/305557624.md)
- [Kava Lend loses roughly $3.8 million to hack, sending KAVA token down nearly 40%](https://longbridge.com/en/news/305556359.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**